Current
$393.10B
5-Year Average
$297.41B
All-Time High
$433.04B
All-Time Low
$52.14B
Market cap daily chart for AbbVie (ABBV)
Jun 16, 2021 – Jun 15, 2026 · 1,255 trading days
Market Cap growth chart for AbbVie (ABBV) from 2012 to 2026
Latest: -3.0%
Market Cap history table for AbbVie (ABBV) from 2012 to 2026
| 2026 | $393.10B | -3.0% | −$12.24B | ||
| 2025 | $405.34B | +28.7% | +$90.28B | ||
| 2024 | $315.06B | +14.7% | +$40.30B | ||
| 2023 | $274.76B | -4.4% | −$12.58B | ||
| 2022 | $287.34B | +19.4% | +$46.74B | ||
| 2021 | $240.61B | +34.2% | +$61.34B | ||
| 2020 | $179.26B | +36.4% | +$47.87B | ||
| 2019 | $131.39B | -7.8% | −$11.13B | ||
| 2018 | $142.53B | -8.1% | −$12.50B | ||
| 2017 | $155.03B | +51.8% | +$52.89B | ||
| 2016 | $102.13B | +5.3% | +$5.16B | ||
| 2015 | $96.98B | -8.0% | −$8.38B | ||
| 2014 | $105.36B | +24.4% | +$20.65B | ||
| 2013 | $84.71B | +57.2% | +$30.84B | ||
| 2012 | $53.87B | — | — |
- 2026$393.10B-3.0%
- 2025$405.34B+28.7%
- 2024$315.06B+14.7%
- 2023$274.76B-4.4%
- 2022$287.34B+19.4%
- 2021$240.61B+34.2%
- 2020$179.26B+36.4%
- 2019$131.39B-7.8%
- 2018$142.53B-8.1%
- 2017$155.03B+51.8%
- 2016$102.13B+5.3%
- 2015$96.98B-8.0%
- 2014$105.36B+24.4%
- 2013$84.71B+57.2%
- 2012$53.87B—
Market Cap values are taken from AbbVie's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at AbbVie (ABBV)
According to AbbVie's latest reported financial statements, the company's latest reported market cap is $385.83B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2026's annual market cap for AbbVie (ABBV) came in at $393.10B – edged down 3.0% year-over-year.
Looking at the 2021–2026 (5 years) stretch, AbbVie market cap compounded at +10.3% per year, with mixed annual results across the window.
Between 2025 and 2026, AbbVie market cap edged down 3.0%, falling from $405.34B to $393.10B.
Across the available history, market cap reached its high of $405.34B in 2025 and its low of $53.87B in 2012.
AbbVie Market Cap by Year
AbbVie Market Cap 2026: $393.10B
AbbVie market cap in 2026 was $393.10B, edged down 3.0% below 2025.
AbbVie Market Cap 2025: $405.34B
2025's market cap for AbbVie came in at $405.34B, grew 28.7% from 2024. This figure represents the highest annual value in the available history.
AbbVie Market Cap 2024: $315.06B
AbbVie posted market cap of $315.06B in 2024, grew 14.7% from 2023.
AbbVie Market Cap 2023: $274.76B
In 2023, AbbVie reported market cap of $274.76B, edged down 4.4% below 2022.
AbbVie Market Cap 2022: $287.34B
AbbVie market cap in 2022 was $287.34B.
See more financial history for AbbVie (ABBV).
Sector peers by Market Cap
Healthcare peers of AbbVie (ABBV), ranked by their latest market cap
| $1.06T | |
| $567.28B | |
| $373.28B | |
| $283.78B | |
| $274.92B | |
| $195.17B | |
| $189.18B | |
| $176.04B |
- $1.06T
- $567.28B
- $373.28B
- $283.78B
- $274.92B
- $195.17B
- $189.18B
- $176.04B
Frequently asked questions
AbbVie (ABBV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation